Overexpression of HPIP as a biomarker for metastasis and prognosis prediction in endometrial cancer patients

scientific article published on 26 June 2019

Overexpression of HPIP as a biomarker for metastasis and prognosis prediction in endometrial cancer patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/JCLA.22959
P932PMC publication ID6805295
P698PubMed publication ID31241209

P50authorFanling MengQ93038438
P2093author name stringLi Cheng
Yao Wang
Shiguo Li
Tingting Zhao
Hui Fei
P2860cites workHPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasionQ35210586
The interplay between HPIP and casein kinase 1α promotes renal cell carcinoma growth and metastasis via activation of mTOR pathwayQ37426764
Expression of HPIP in epithelial ovarian carcinoma: a clinicopathological studyQ37536372
Elevated fibrous sheath interacting protein 1 levels are associated with poor prognosis in non-small cell lung cancer patientsQ37707070
HPIP silencing inhibits TGF-β1-induced EMT in lung cancer cellsQ38721946
HPIP promotes gastric cancer cell proliferation through activation of cap-dependent translationQ38740637
HPIP Silencing Prevents Epithelial-Mesenchymal Transition Induced by TGF-β1 in Human Ovarian Cancer CellsQ38770975
HPIP promotes non-small cell lung cancer cell proliferation, migration and invasion through regulation of the Sonic hedgehog signaling pathwayQ38800742
HPIP promotes thyroid cancer cell growth, migration and EMT through activating PI3K/AKT signaling pathwayQ38828181
Cancer Statistics, 2017.Q39038674
HPIP: a predictor of lymph node metastasis and poor survival in cervical cancer.Q46178743
A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma.Q47204629
HPIP expression predicts chemoresistance and poor clinical outcomes in patients with epithelial ovarian cancerQ48746569
Whole-genome characterization of chemoresistant ovarian cancerQ50272478
HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activationQ52808198
P433issue8
P921main subjectbiomarkerQ864574
endometrial cancerQ944777
P304page(s)e22959
P577publication date2019-06-26
P1433published inJournal of Clinical Laboratory AnalysisQ15754724
P1476titleOverexpression of HPIP as a biomarker for metastasis and prognosis prediction in endometrial cancer patients
P478volume33

Search more.